Status | Study |
Recruiting |
Study Name: Proteinuria During Acute Pyelonephritis In Pregnancy Condition: Proteinuria Date: 2015-08-28 Interventions: Other: Exposure to pyelonephritis Pyelonephritis group are patients with exposure to pyelonephritis With |
Recruiting |
Study Name: A Crossover Pilot Study of the Effect of Amiloride on Proteinuria Condition: Proteinuria Date: 2015-07-23 Interventions: Drug: Amiloride 5mg twice a da |
Withdrawn |
Study Name: Acthar on Proteinuria in IgA Nephropathy Patients Condition: IgA Nephropathy Proteinuria Date: 2015-01-09 Interventions: Drug: Acthar 80 unit injection Subjects not responding aft |
Active, not recruiting |
Study Name: Belatacept Conversion in Proteinuric Kidney Transplant Recipients Condition: Proteinuria Date: 2014-12-22 Interventions: Drug: Belatacept Conversion from calcineurin-inhibitor to Belatacept maintenance immunosuppression. |
Recruiting |
Study Name: Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria Condition: Proteinuria Date: 2014-09-03 Interventions: Drug: Losartan 12 weeks of los |
Completed |
Study Name: Association Between Basal Proteinuria Levels and Pregnancy Outcomes in Familial Mediterranean Fever Condition: Basal Proteinuria in Pregnancy Date: 2014-03-17 |
Completed |
Study Name: Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD Condition: Chronic Kidney Disease Proteinuria Date: 2013-03-19 Interventions: Drug: Calcitriol Calcitriol 0.5 ug/BIW for 24 weeks. |
Completed |
Study Name: Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose Condition: We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria. Date: 2012-11-28 Interventions: Drug: Amlodipine 10 mg/day for 12 weeks |
Completed |
Study Name: The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria Condition: Chronic Kidney Disease Proteinuria Date: 2012-02-11 Interventions: Drug: aliskiren, eplerenon, telmisartan aliskiren (Rasilez 300 mg, Novartis Europharm eplerenon (Inspra |
Completed |
Study Name: Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients Condition: Disorder of Transplanted Kidney Proteinuria Date: 2011-09-14 Interventions: Drug: Paricalcitol 2 microgram |